Agents with a dominant or highly significant glutamatergic (gluatminergic/glycinergic) pathway(s) modulating mechanism of action
Tianeptine Sulfate (Tianeptine Hemisulfate Monosodium Salt) is a novel pseudo-analogue of Tianeptine wherein the substituted hemisulfate monosodium salt creates a duration of in vivo activity that far exceeds that of the parent as well as the prior commercially available existing sodium salt form. Research Indications: Antidepressant Research,...
SNRB-MEGA is a proprietary TeamTLR developed Mega-Efficacy Ultra-Potent Selective NMDA Antagonist Neurogenic-Synaptogenic Antidepressant with astounding potency and efficacy across the spectrum of antidepressant, anxiolytic, and neurogenic-synpatogenic animal model paradigms. Research Indications: Antidepressant Research, Neurogenic Research,...
SNRB-OX is a proprietary Optimized Xtract Scientifically Engineered Selective NMDA Receptor Subunit 2B (NR2B) Low-Efficacy Weak Partial Agonist with Functional Antagonist activity. Research Indications: antidepressant, anxiolytic, neuroprotectant, neuroregenerative, and congnition enhancement research. Supplied in solution
GLYX-OA aka GLYXtract is a Proprietary Bio-Guided Fraction Optimized First-In-Class NMDA Glycine-Site Specific Functional Antagonist Xtract with potent antidepressant, neurogenic, and cognition enhancement efficacy that displays no adverse effects. Research Indications: Antidepressant, Analgesic, Procognitive, Neurogenic, Anti-inflammatory, Anti-Aging
NRTB-OX Proprietary Optimized NR2B[NMDA complex] inhibiting modulator Xtract the possesses a unique ability to cleanly modulate the NRB2[NMDA] complex in a synergistic manner that appears worthy of further research exploration within both antidepressant and analgesic paradigms. Research Indications: Antidepressant, Analgesic
Fasoracetam (a.k.a. NS-105 and LAM-105) is a potent HACU-inhibiting, cAMP-modulating, GABAB receptor upregulating/antagonizing, mGluR-modulating, non-monoaminergic anti-depressant nootropic. Research Indications: Nootropic, Antidepressant, Anxiolytic, ADHD Research, Addiction Cessation, GABAergics/Benzodiazepine Research
NRX-1074 is an NMDA Glycine-Site Functional Weak Partial Agonist with potent efficacy demonstrated for treatment of depression. It as well has neurogenic/synaptogenic and nootropic/cognitive enhancing properties. Research Indications: Antidepressant, Neurogenic, Nootropic Research